Results: Similar lowering effects on total cholesterol, low density lipoprotein (LDL)-cholesterol, triglyceride and apoB levels were seen after the two diets. Slightly higher levels of high-density lipoprotein (HDL)-cholesterol (1.4 AE 0.4 vs 1.3 AE 0.4 mmolal, P`0.0001) and apoA-1 (1.2AE 0.3 vs 1.1 AE 0.3 mmolal, P`0.05) were found in the MUFA-diet. Furthermore, the insulin sensitivity, as assessed by Bergman's minimal model, and the ®rst response insulin areas were similar, as were the 24-h blood pressures and the von Willebrand Factor (vWF) levels. Conclusions: Isocaloric diets rich in MUFA or rich in carbohydrate, respectively, seem to have similar effects on cardiovascular risk factors in persons at high risk of developing Type-2 DM. A potential risk, however, on body weight of high-fat diets should be kept in mind.
Introduction
Type-2 diabetes mellitus (Type-2 DM) is connected with a two to threefold increase of the risk of coronary heart disease, compared with non-diabetics of same age and gender (Kannel & McGee, 1979; Heyden et al, 1980; Barrett-Connor & Wingard, 1983; Jarrett & Shipley, 1985; Uusitupa et al, 1985) . The cornerstone in the treatment of Type-2 DM is dietary intervention, and in several years the prescribed diet has been rich in carbohydrate whereas interest in metabolic effects of different fatty acids has come later. However, several studies have displayed bene®cial metabolic effects of dietary monounsaturated fatty acids (MUFA) in Type-2 DM (Garg et al, 1988; Bonanome et al, 1991; Garg et al, 1992a Garg et al, , 1992b Rasmussen et al, 1993; Thomsen et al, 1995a; Lerman-Garber et al, 1994a , 1994b Nielsen et al, 1995) . Interestingly, we recently showed bene®cial effects of MUFA diets on the diurnal blood pressure and von Willebrand Factor (vWF) in normotensive Type-2 DM subjects without proteinuria, both compared with a diet rich in carbohydrate (Rasmussen et al, 1994 ) and a diet rich in polyunsaturated fatty acids (Thomsen et al, 1995a (Thomsen et al, , 1995b .
Type-2 DM has a strong genetic component as evidenced by the high concordance rate in monozygous twins (Newman et al, 1987) . Furthermore, it has been estimated that 60% of ®rst-degree Type-2 DM relatives will have abnormal glucose tolerance at the age of 60 years and that more than 40% of ®rst-degree Type-2 DM relatives ultimately develop the disease (Ko Èbberling and Tillil, 1982; Ko Èbberling et al, 1985) . Hyperinsulinaemia, relative weight (Haffner et al, 1989 (Haffner et al, , 1990 and 2-h glucose (McCance et al, 1994) seem to be highly predictive of subsequent diabetes. In addition, a high prevalence of dyslipidaemias in ®rst-degree Type-2 DM relatives has been demonstrated (Schumacher et al, 1992) . Preventive measures against these risk factors in subjects with high risk of developing Type-2 DM are important, and effective dietary intervention would be desirable. The diabetic population is recommended to reduce the intake of saturated fat. Furthermore, in lean diabetic persons an exchange of carbohydrate by MUFA can be used if a low-fat diet elevate triglyceride levels.
The dietary changes in diabetic patients will de®nitely affect the dietary habits of their family members and may in¯uence risk factors for the development of diabetes in their children. However, no studies so far have investigated the effects of dietary MUFA in subjects with high risk of developing Type-2 DM.
In this study we wanted to study the metabolic effects of two diets primarily differing by exchanging carbohydrate by MUFA in potential prediabetic subjects. Thus, we compared the effects of a MUFA-rich diet and a carbohydrate-rich diet on vWF levels, 24-h blood pressure, lipids and lipoproteins, insulin sensitivity, and glycaemic control in normoglycaemic ®rst-degree relatives of Type-2 DM subjects.
Methods

Subjects
Two hundred well-de®ned Type-2 DM patients from the outpatient clinic were asked to get their biological children with age above 18 years to contact the study team; 40 potential participants attended an information meeting. Twenty-®ve persons accepted to participate and had an oral glucose tolerance test (OGT), 18 agreed to participate in the study, two of these dropped out just before the ®rst intervention period. Of the 16 participants (10 women, six men), nine had one parent with veri®ed diabetes, seven had additionally at least one relative with veri®ed Type-2 DM. They had an average age of (mean AE s.d.) 35 AE 2 years and were slightly overweight (weight: 77.3 AE 4.3 kg, body mass index: 25.8 AE 1.0 kgam 2 ). All participants had a normal OGT, were normotensive and normolipidaemic. None of the subjects had clinical evidence of endocrine, cardiac, hepatic or renal diseases, nor were they taking any medication, including hormonal therapy. None of the participants had been treated for obesity. Three of the participants were smokers (less than ®ve cigarettesaday). The participants all had moderate physical activity with maximal 2 hours of sport activities per week. The study had approval from the local ethical committee of Aarhus County.
Experimental protocol
A crossover study was carried out. After a 4-week run-in period taking their habitual diet (baseline diet), the participants were randomly allocated to 4-week treatments with either a high-carbohydrate (CHO) or a high monounsaturated fatty acid (MUFA) diet. After a 4-week wash-out period on the habitual diet, the participants received the alternative diet for 4 weeks. The calorie content of the diets was calculated individually according to 4 days diet records in the run-in period. To avoid an insuf®cient energy intake in the intervention periods, the energy intake was adjusted, if needed, according to the Harris ± Benedict equation, which was multiplied by appropriate factors for activity (Pellett, 1990) . The participants weighed themselves daily at home and were instructed to contact the dietitian if the body weight changed more than 500 g. The participants kept a diary concerning any unusual situation during daily life during the investigation. At least once weekly the participants were weighed without shoes, jackets and sweaters at the clinic and had their experimental food delivered by the dietitian. For each patient the two diets were isocaloric with a mean energy content of 9.6 AE 0.3 MJad. The study was carried out on free-living subjects. Fasting blood glucose, lipids and lipoproteins and vWF level was measured before and on the last day of the two diet periods. Frequently sampled intravenous glucose tolerance tests (FSIGT) and 24-h ambulatory blood pressures were measured at the last days of the two diets. Furthermore, the patients collected a 24-h urine sample.
Dietary interventions
Before the study began and during the last week of the diet interventions, the participants weighed and recorded their foods for 3 working days and 1 weekend day to estimate the energy intake and composition. The dietitian coded the food records and the nutrient content was calculated by the computer program Dankost (Dankost, 1980) . The validity of the database was ensured by analyses of fatty acid composition of several dishes by HPLC. The nutrient composition is given in Table 1 . Our intention was to prescribe a low-fat, high-carbohydrate (CHO) diet providing 55% of energy (E%) as carbohydrate and 30% as fat (10% MUFA), and a diet with high content of MUFA (MUFA diet) by switching 15 E% from the carbohydrates to MUFA, prescribing 40% as carbohydrate and 40% as fat (25% MUFA).
Olive oil (cold pressed virgin olive oil, Elanthy, Piraeus, Greece) was used as the MUFA source in the MUFA diet. Special meat dishes were manufactured in the hospital kitchen and delivered frozen to the participants. We delivered dishes, special rolls and cake. During the CHO diet period the dishes contained 10 g of grape-seed oil (a common oil in the Danish household), the rolls and cake had low content of fat, primarily polyunsaturated fat. During the MUFA diet period the dishes contained 30 g, the rolls 7 g and the cake 7 g olive oil. The participants were maximal given ®ve rollsaa day and two pieces of cake per week. As an example: a person having 10,000 kJad was during the MUFA diet period prescribed 107 g fat, which was achieved by 70 g fat from the dishes, the rolls, cake and eventually from almonds, and the rest by addition of olive oil to the food. Olive oil contributed 23% of total energy intake during the MUFA diet period. Monounsaturated fatty acids and ®rst degree relatives to Type-2 diabetic subjects C Thomsen et al
The CHO diet was enriched mostly by bread, potato and rice. Apart from the delivered food, accounting on average for 70% of the total energy, the participants received individual dietary prescriptions concerning the remaining food. Apart from the food, subjects continued their habitual eating pattern and activities of daily living.
The participants visited the dietitian every week. The food scheme had to be reviewed and the calorie intake adjusted if body weight differed more than 500 g from the weight at the start. Furthermore, the participants were instructed and encouraged to contact the dietitian before special events, such as dinner at friends. The diet was then adjusted, if needed, and we ensured that such events in fact were recorded and were not kept concealed for us.
Before the ®rst diet period and on the last day of the diet, plasma samples were drawn for analysis of the fatty acid composition of the plasma triglycerides.
24-h ambulatory blood pressure Ambulatory blood pressure was measured by means of a portable automatic monitor (SpaceLabs model 90207, Redmond, Washington, USA), which has been recommended for clinical use (O'Brien et al, 1991) . This was carried out on one of the last days of the 4-week treatments with the CHO and MUFA diets. The equipment measures blood pressure by oscillometry and was programmed for cuff insuf¯ation every 20 min from 0600 to 2400 h, and every hour during the night.
A 24-h urine sample was collected concomitantly with the 24-h blood pressure measurement and was analysed for glucose, sodium, potassium, albumin and creatinine.
Intravenous glucose test (FSIGT)
The FSIGT tests were done on the last days of the two diet periods. After placement of two intracatheters, one in each antecubital vein, four basal blood samples were collected over 20 min from one of the catheters. At time t 0 a 300 mgakg body weight i.v. glucose load was given in the opposite catheter over 1 min as a 25% solution. Blood samples for glucose and insulin assay were collected at the following times: 2, 3, 4, 5, 6, 8, 10, 12, 14, 16, 19, 22, 24, 25, 27, 30, 40, 50, 60, 70, 80, 90, 100, 120, 140, 160 and 180 min. The analysis of the FSIGT data was based on Bergman's Minimal Model of glucose disappearance and insulin kinetics (Bergman, 1989; Pickering, 1990 ). The minimal model of glucose disappearance yields two parameters: the insulin sensitivity index, S i , and the glucose sensitivity index or glucose effectiveness, S g (Bergman, 1989) . The insulin sensitivity index represents the increase in net fractional glucose clearance rate per unit change in plasma insulin concentration following the intravenous glucose load and is highly correlated to the insulin sensitivity as assessed by the clamp method (Pickering, 1990) . Glucose effectiveness represents the net fractional glucose clearance rate simply due to the increase in glucose itself in the absence of any increase in insulin concentration above baseline (Bergman, 1989) . The acute insulin response to intravenous glucose was calculated as the incremental plasma insulin concentrations from 0 to 6 min following the intravenous glucose bolus (Kahn et al, 1993) .
von Willebrand Factor
The plasma vWF level thought to re¯ect the endothelial function (Editorial, 1988) seems to be highly indicative of endothelial injury in non-diabetic conditions (Boneu et al, 1975; Blann and McCollum, 1994) and in Type-2 DM patients (Porta, 1988; Solerte et al, 1985; Conlan et al, 1993 , Blann, 1993 Schmitz and Ingerslev, 1990) . In fact, the plasma vWF level is considered the best available marker of endothelial injury in Type-2 DM at present (Stehouwer et al, 1992) .
Analytical methods
Plasma glucose levels were measured by a glucose oxidase method [coef®cient of variation (CV): 3.8%]. Serum insulin was determined by a ELISA method (CV: 1.7% Andersen et al, 1993) . HbA 1c was measured by a commercial kit (Bio-Rad, Richmond, CA, USA), normal 3.5 ± 5.5% (CV: 5%). Triglyceride and lipoproteins were measured on Enichom Chem 1 analyser (CV triglyceride : 4%, CV total cholesterol : 1.7%, CV HDL cholesterol : 6%). Citrated blood (1 part trisodium citrate, 9 parts blood) was aspirated and quickly centrifuged to obtain platelet-poor plasma, was used for measurement of vWF by ELISA (Ingerslev, 1987;  reference range 1.02AE 0.25 IUaml, CV: 5.1%), ®brinogen, ®bronectin and a 2 -macroglobulin by nephelometry (CV: 4.1 ± 4.6%; Laurell, 1966) . The standard for vWF was a pool of normal plasma calibrated against the First International Standard Preparation for plasma factor VIII. A commercial plasma standard (Behringwerke, Marburg, FRG) was employed for nephelometric determinations. Apo A-1 and apoB were measured by commercial RIA kits (Mercodia, Uppsala, Sweden; CV apo A-1 : 3.1%, CV apo B : 4.4%).
To determine the fatty acid composition of the plasma triglycerides 500 ml fasting plasma was mixed with 6 ml chloroform and 3 ml methanol containing 0.005% butylated hydroxytoluene (BHT, Sigma B-1378), and mixed with 2.4 ml 0.88% KCl. The chloroform phase were evaporated to dryness and dissolved in 200 ml tetra-hydrofurane (Merck 9731) containing 0.0005% BHT. The sample was then incubated with 400 mL NaOCH 3 at 50 C for 10 min and neutralised with 20 mL glacial acetic acid. After extraction the fatty acid methyl esters were separated by gas ± liquid chromatography on a 25-m capillary column with helium as a carrier gas.
Statistical methods
According to power calculations to ensure a statistical power of 0.8, the required number of participants was 12. The results are expressed as mean AE s.d. Student's t-test for paired data or multiple comparisons were made by analysis of variance (repeated measures) followed by Fisher's Least Signi®cance Test (RM-ANOVA, BMDP Statistical Software, Berkeley, CA, USA). P`0.05 was considered statistically signi®cant.
Results
All subjects followed the protocol and had no problems eating either of the diets as judged by the individual diaries. The participants succeeded well concerning the change in diets during both periods (Table 1 ). The reported intake during the two periods was con®rmed by the changes in the composition of plasma triglyceride fatty acids (Table 2) : during the CHO diet period an increase of linoleic acid was seen and during the MUFA diet period a substantial increase in oleic acid was seen. The fasting blood glucose levels were similar before the two diet periods (Table 3) . On both diets the patients had similar weight loss averaging 1.5 kg on the CHO diet vs 1.6 kg on the MUFA diet Monounsaturated fatty acids and ®rst degree relatives to Type-2 diabetic subjects C Thomsen et al (P 0.46), i.e. on average less than 2% from baseline. The MUFA diet and the CHO diet seemed to have similar neutral impact on the fasting blood glucose levels (Table  3) . No glucosuria was detected and the urinary excretions of sodium, potassium and creatinine were similar and within normal limits. We found no indications of gender or period effects.
24-h ambulatory blood pressure
All participants had normal blood pressure. Similar blood pressures (BP) at the end of the MUFA and CHO diet periods were seen, 24-h systolic BP 122 AE 11 vs 120 AE 9 mmHg (P 0.51) and diastolic BP 76 AE 9 vs 75 AE 7 mmHg (P 0.64), respectively. Furthermore the pulse rates were similar (78 AE 12 vs 76 AE 14 beats per minute (P 0.50)), indicating similar levels of physical activity.
FSIGT (Minimal Model)
In Table 4 it can be seen that the participants had similar fasting blood glucose and insulin levels at the end of the two diet periods. The peak levels of glucose were highest after the CHO diet period (Table 4) . Otherwise no differences were found in insulin peak values, 6 min or 180 min incremental insulin areas after the intravenous glucose loads. Both the insulin sensitivity index, S i and the glucose sensitivity index, S g were similar after the two diet periods.
Lipids and lipoproteins
In Table 3 the fasting glucose, lipid and lipoprotein levels at the start and at the end of each intervention period are given. The MUFA and CHO diets induced similar lipid, lipoprotein and apoB levels at the end of the two diet periods. A more pronounced decrease of high-density lipoprotein (HDL) cholesterol during the CHO diet period ( 7 14.8 AE 12.8% vs 7 7.7 AE 15.9%, P`0.02) were seen, resulting in higher HDL level after the MUFA diet than after the CHO diet period. This ®nding was corroborated by the apoA-1 levels, which were higher after the MUFA diet period (Table 3) .
von Willebrand Factor
No differences in vWF, ®brinogen, ®bronectin and a-2 macroglobulin levels at the start or at the end of the MUFA and the CHO diet periods were seen. No impact on vWF or ®brinogen levels were found during any of the two diets just as no differences were found concerning the control parameters, ®bronectin and a-2 macroglobulin. All participants had vWF levels within the normal reference level (around 0.87 AE 0.27 IUaml).
Discussion
In this study we wanted to study the metabolic effects of two diets primarily differing by switching carbohydrate by MUFA in potential prediabetic subjects, that is ®rst-degree relatives of Type-2 DM subjects. The participating women were all premenopausal, however, since the intervention and wash-out periods were all of 4 weeks durations the possibility of the in¯uence of hormonal cycle effects was minimised. The study was a randomised crossover study and statistical analyses were done as within person comparisons, which ensured a high degree of statistical power.
The adherence to diets was ensured by the distribution of prepared study foods and was con®rmed by the participant's diaries and the analyses of fatty acid composition in plasma triglycerides. Furthermore, the use of a crossover rather than a parallel design reduces the risk of differential adherence to the two diets.
The participants in this study were slightly overweight, but were otherwise healthy and had normal OGTTs. On this time of their lives, we de®nitely cannot identify who will become future Type-2 DM patients by any test. However, these persons are all at high risk of developing Type-2 DM merely because they are all offspring of Type-2 DM subjects (Ko Èbberling and Tillil, 1982; Ko Èbberling et al, 1985) , some even had additional relatives with Type-2 DM. In a study by Stewart and co-workers (Stewart et al, 1995) a higher incidence of impaired glucose tolerance (IGT) was demonstrated in ®rst-degree relatives of Type-2 DM persons. In a low risk population the rate of conversion to Type-2 DM from IGT was very high in elderly subjects (23% in 3.5 years) in a study from Finland (Mykka Ènen et al, 1993) . In this study we only included younger glucose tolerant persons with genetic predisposition to Type-2 DM, for which reason any bene®cial or deleterious response to Monounsaturated fatty acids and ®rst degree relatives to Type-2 diabetic subjects C Thomsen et al the diets would likely be exaggerated in ®rst-degree relatives with IGT. The exchange of carbohydrate by MUFA was substantial (Table 1 ). The fat content of the MUFA diet is very similar to the fat content of the average Danish diet. Thus, the national dietary survey in 1985 (Haraldsdo Âttir et al, 1995) showed an average fat intake corresponding to 42 ± 43% of energy intake. There were no differences between the two diets with respect to the ®bre content, the amount of saturated or polyunsaturated fat, alcohol, energy or resulting changes in body weight. A smaller difference in protein intake was seen between the CHO and MUFA diets (Table  1) , attaining 10 g protein per day. In Type-2 DM subjects only larger amounts of protein ( b 30 g) would in¯uence glucose or insulin responses (Nuttall et al, 1984; Rasmussen et al, 1990) . In our study no difference in either glucose or insulin levels were seen, for which reason it seems unlikely that the observed difference in protein ingestion in¯uenced the results in this study.
The participants had normal levels of total, HDL-and LDL-cholesterol (Table 3) . However, the total cholesterol levels were relatively high in the normal range, which is in accordance with previous reports in ®rst-degree Type-2 DM relatives (Schumacher et al, 1992) . Interestingly, the MUFA diet had a HDL-cholesterol conserving effect as compared with the CHO diet. Both diets had decreasing effects on the total-and LDL-cholesterol levels of at least 13%. Based on observational and clinical trial data, it has been estimated that a 1% reduction in the plasma total cholesterol concentration leads to an approximately 2 ± 3% reduction in risk of coronary heart disease (National Institutes of Health, 1984; American Heart Association and National Heart, 1990). On this basis, a reduction in the risk of coronary heart disease by at least 25% might be expected simply by changing the habitual diet to either a CHO rich or a MUFA rich diet. Furthermore, according to estimated risk pro®les (Wood et al, 1998) , the risk of coronary disease were reduced equally by the two diets accounting for a decrease in risk for the non-smokers from mild risk (5 ± 10%) to low risk (under 5%) and the smokers from moderate (10 ± 20%) to mild. A carbohydrate-induced hypertriglyceridemia may be a potential disadvantage of a high carbohydrate diet in Type-2 DM (Garg et al, 1992a , Coulston et al, 1987 , but in this study no signi®cant impact was found on the triglyceride levels in ®rst-degree Type-2 DM relatives of neither of the diets. HDL-cholesterol concentrations show a strong, independent inverse correlation with cardiovascular risk (Miller, 1987) , for which reason the MUFA diet may have additional bene®cial effects against the development of coronary heart disease as compared with a CHO-rich diet. Studies in ®rst-degree Type-2 DM relatives with normal glucose tolerance have demonstrated an early impairment of glucose metabolism (Eriksson et al, 1989) . We found similar insulin sensitivity (S i ) and glucose effectiveness (S g ) after the two diet periods (Table 4) . Furthermore, no indications of a difference in the insulin secretory capacity was found judging by the similarity in peak insulin levels and insulin areas during the FSIG tests. No difference was found in fasting levels of glucose or insulin for which reason the two diets evidently had similar impact on the glucose metabolism. A potential risk of weight gain of high-fat diets (Al®eri et al, 1997; Golay and Bobbioni, 1997) has been reported, however, no such effect seems to be pronounced under isoenergetic conditions (Seidell, 1998 ). It appears probable, however, that larger metabolic effects of diets might occur in older more overweight and sedentary subjects.
Interestingly, all the participants had vWF levels within our reference range for healthy subjects. The blood pressures too were normal and similar after the two diet periods. In contrast, we earlier found in Type-2 DM subjects higher vWF levels despite normal blood pressure levels (Rasmussen et al, 1994; Thomsen et al, 1995b) . These results indicate that the participating ®rst-degree Type-2 DM relatives had no injury on the endothelium that may be re¯ected by an increase of the vWF levels.
In summary, the present data demonstrate that 4 weeks' treatments with a diet rich in MUFA and a diet rich in carbohydrate induced similar levels of triglyceride and total and LDL cholesterol levels in overweight ®rst-degree relatives of Type-2 DM subjects. The MUFA diet in addition had a HDL-cholesterol conserving effect. Similar effects on the endothelial function, diurnal blood pressure and the insulin sensitivity were found. Consequently, isocaloric diets rich in MUFA or rich in carbohydrate, respectively, seems to have similar effects on cardiovascular risk factors in persons at high risk of developing Type-2 DM.
